Brief introduction of Henan tailong pharmaceutical co., ltd.

The company has a registered capital of 317.22 million yuan, more than 6,000 employees and an annual output value of 400 million yuan. Its main economic indicators are among the best in the pharmaceutical industry in Henan Province. In 2006, 5438+0 passed the certification of the Ministry of Science and Technology and was recognized as the key high-tech enterprise of the national torch plan. In 2003, it was awarded the title of "National Tax Exemption Enterprise" by Zhengzhou State Taxation Bureau, "Excellent Enterprise in Zhengzhou City" by National Development and Reform Commission and "National High-tech Industrialization Demonstration Project". The registered trademark of the company has also been recognized as a "famous trademark in Henan Province" by Henan Administration for Industry and Commerce. In 2006, it was approved by the Ministry of Personnel as a post-doctoral workstation substation.

Henan Tailong Pharmaceutical Co., Ltd. (formerly Henan Zhu Lin Zhongsheng Pharmaceutical Co., Ltd.) is a joint-stock company approved by Henan Economic System Reform Committee (1998) No.38, with Zhengzhou Zhongsheng Industrial Group Co., Ltd. as the main sponsor, Henan Zhiyi Investment and Development Co., Ltd., Zhengzhou Zhu Lin Zhu Xian Washing Products Co., Ltd., Zhengzhou Zhu Lin Refractory Company and gongyi city Zhu Lin Xinhua Packaging Material Factory as the joint-stock company. The company was established on 3 1, 1, in August, 998. Approved by China Securities Regulatory Commission [1999] No.98, Japanese companies issued 35 million public shares in August1999. On March 24th, 2006, the Japanese company name was changed from "Zhu Lin Zhongsheng Pharmaceutical Co., Ltd. in Henan Province" to "Tailong Pharmaceutical Co., Ltd. in Henan Province". At present, the company's main products include Shuanghuanglian oral liquid series, Lian Shuangjin mixture, Qingre Jiedu oral liquid, Xiere mixture, Xiaoer Qingre Zhike oral liquid, Xiaoer antipyretic oral liquid, compound Mu Yi oral liquid, Wujin oral liquid, Jinguoyin oral liquid, Shengmaiyin oral liquid, Maiwei Dihuang oral liquid, Shuanghuanglian capsule, Habain tablets, phenoxybenzamine hydrochloride tablets, Chuanhuning and other Chinese and western medicines, including oral liquid, capsules, tablets and granules. Among them, Shuanghuanglian oral liquid is mainly used to treat upper respiratory tract infections such as pneumonia, tracheitis, pharyngitis and tonsillitis caused by viruses and bacteria, fever, sore throat, cough and senile asthma caused by colds and viral influenza. With unique antibacterial and antiviral effects, it has been listed as a medical protection product in China by the state. He was awarded the gold medal of the first China Jinbang Technology and Products Expo, the first prize of excellent products in Zhengzhou, and the title of famous brand products in Zhengzhou. It was recognized as a high-tech product by Henan Science and Technology Commission, and it was the only traditional Chinese medicine oral liquid that entered Henan brand products in Henan Pharmaceutical Administration 1998. In 2000, it was recognized as a "well-known commodity in Henan Province" by the Henan Provincial Administration for Industry and Commerce and listed in the national medical insurance drug list.

Lian Shuangjin mixture is a new broad-spectrum antiviral and antibacterial drug, which is mainly used to treat fever, cough and sore throat caused by exogenous wind and cold. It is an alternative product of Shuanghuanglian oral liquid independently developed by the company. Compared with Shuanghuanglian oral liquid, it has the advantages of strong antiviral effect, rapid antipyretic, no rebound and early recovery, and the antipyretic effect is equivalent to that of similar chemicals. This product will gradually become the new main product pillar of the company.

Habain is a reversible and powerful acetylcholinesterase inhibitor, which can promote memory reproduction and enhance memory retention. It is an internationally recognized safe and effective drug for the treatment of memory disorders and various dementia, memory, cognitive function and emotional behavior disorders in middle-aged and elderly people. It has obvious curative effect on improving memory and preventing dementia./kloc-0 was rated as a national new product by the State Economic and Trade Commission in 1997. Phenoxybenzamine hydrochloride is a high-quality and efficient adrenergic α receptor blocker, which has special effects on dysuria caused by non-mechanical obstruction caused by benign prostatic hyperplasia. It was designated as a recommended product by Shanghai Branch of Chinese Medical Association, and won the second prize of national and ministerial level scientific and technological progress, the first prize of Henan province scientific and technological progress, the first prize of provincial famous products and the first prize of municipal scientific and technological progress. At present, the company's main dosage forms production workshops have passed the GMP certification of the US Food and Drug Administration. In terms of product quality control, the company thoroughly implemented the Drug Administration Law and good manufacturing practice (GMP), strengthened drug quality awareness, and ensured safe and effective drug use. Over the years, the first pass rate of product quality has reached 100%.